INDUSTRY NEWS
China Absorbent Hygiene Products Expo,China Feminine Care Products Exрo- 2026-08
20
Chongqing Hetai Runjia Achieved Operating Revenue of RMB 163 Million in 2025
Chongqing Hetai Runjia Achieved Operating Revenue of RMB 163 Million in 2025 Chongqing Hetai Runjia Co., Ltd. recorded an operating revenue of approximately RMB 163 million in 2025, representing a year-on-year increase of 5.98%. Its net profit attributable to shareholders of the listed company stood at around RMB 1.24 million, surging 106.45% year on year, with basic earnings per share reaching RMB 0.02, up 106.45% year on year. The revenue generated from core business declined by 5.83% compared with the previous reporting period, mainly attributable to intensified market competition and price fluctuations in the packaging bag sector during the reporting period. - 2026-08
20
OK Science and Technology Estimates Operating Revenue of RMB 458 Million to RMB 505 Million for H1 2026
OK Science and Technology Estimates Operating Revenue of RMB 458 Million to RMB 505 Million for H1 2026 OK Science and Technology Co., Ltd. estimates its operating revenue for the first half of 2026 will range from RMB 458 million to RMB 505 million, representing a year-on-year growth of 0.67% to 10.96%. The net profit attributable to shareholders of the listed company is projected to be between RMB 17.6806 million and RMB 23.0892 million, a year-on-year decrease of 66.58% to 74.41%. The basic earnings per share is expected to stand at RMB 0.1353 to RMB 0.1767. - 2026-08
20
C&S Paper Releases 2026 H1 Performance Forecast, Projected Net Profit Up 46.52% to 53.18%
C&S Paper Releases 2026 H1 Performance Forecast, Projected Net Profit Up 46.52% to 53.18% C&S Paper Co., Ltd. forecasts that its net profit attributable to shareholders of listed companies for the first half of 2026 will range from approximately RMB 220 million to RMB 230 million, representing a year-on-year increase of 46.52% to 53.18%. The net profit after deducting non-recurring gains and losses is expected to hit RMB 218 million to RMB 228 million, rising 48.37% to 55.18% year on year. The basic earnings per share will stand at roughly RMB 0.16 to RMB 0.19. - 2026-06
10
Winner Medical Launches Production Investment Project in Vietnam, Core Product Lines to Achieve Mass Production in Q3 2027
Winner Medical Launches Production Investment Project in Vietnam, Core Product Lines to Achieve Mass Production in Q3 2027 On May 18, the production investment project of Winner Medical Co., Ltd. in Vietnam kicked off at Haihe Industrial Park. With a total investment of approximately 60 million US dollars and a land area of around 93,000 square meters, the project is expected to launch mass production of its core product lines in the third quarter of 2027. - 2026-06
10
Xianhe Co., Ltd. Releases 2025 Annual Report, Plans to Advance Tissue Paper Project at Hubei Base
Xianhe Co., Ltd. Releases 2025 Annual Report, Plans to Advance Tissue Paper Project at Hubei Base In 2025, Xianhe Co., Ltd. posted operating revenue of approximately RMB 12.343 billion, a year-on-year increase of 20.14%. During the reporting period, Hubei Xianhe accelerated the progress of the tissue paper project. The installation and commissioning of production lines were completed ahead of schedule, followed by successful trial runs. The project officially launched production and sales in January 2025, with annual sales volume reaching around 46,900 tons. - 2026-06
01
U-play Achieved Operating Revenue of Approximately RMB 1.168 Billion in 2025
U-play Achieved Operating Revenue of Approximately RMB 1.168 Billion in 2025 Wuhu U-play Nursing Products Technology Co., Ltd. achieved operating revenue of approximately RMB 1.168 billion in 2025, representing a year-on-year increase of 14.43%. Net profit attributable to shareholders of the listed company was approximately RMB 36.1401 million, down 38.89% year-on-year. - 2026-06
01
Jingxing Paper Achieved Operating Revenue of Approximately RMB 6.012 Billion in 2025
Jingxing Paper Achieved Operating Revenue of Approximately RMB 6.012 Billion in 2025 Zhejiang Jingxing Paper Co., Ltd. achieved operating revenue of RMB 6.012 billion in 2025, representing a year-on-year increase of 9.72%. The tissue paper division produced 147,800 tpy of parent tissue roll, up 7.33% year-on-year, of which 137,000 tpy were directly sold externally, up 7.2% year-on-year.
电话：010-64778188 
Email：cidpex@cnppri.com
公众微信号